ALKYLAMINE - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.4
| Stock Code | ALKYLAMINE | Market Cap | 6,574 Cr. | Current Price | 1,285 ₹ | High / Low | 2,449 ₹ |
| Stock P/E | 36.4 | Book Value | 282 ₹ | Dividend Yield | 0.78 % | ROCE | 18.7 % |
| ROE | 14.0 % | Face Value | 2.00 ₹ | DMA 50 | 1,476 ₹ | DMA 200 | 1,719 ₹ |
| Chg in FII Hold | 0.01 % | Chg in DII Hold | 0.13 % | PAT Qtr | 42.3 Cr. | PAT Prev Qtr | 42.9 Cr. |
| RSI | 33.5 | MACD | -66.4 | Volume | 43,201 | Avg Vol 1Wk | 92,254 |
| Low price | 1,212 ₹ | High price | 2,449 ₹ | PEG Ratio | -6.04 | Debt to equity | 0.00 |
| 52w Index | 5.92 % | Qtr Profit Var | -3.43 % | EPS | 35.3 ₹ | Industry PE | 25.2 |
📊 Analysis: ALKYLAMINE shows moderate fundamentals with ROE at 14% and ROCE at 18.7%, which are decent but not exceptional. Debt-to-equity is 0.00, making the company debt-free and financially stable. The P/E ratio of 36.4 is significantly higher than the industry average of 25.2, suggesting overvaluation. Dividend yield at 0.78% is modest. The PEG ratio of -6.04 indicates weak growth prospects relative to valuation. Technical indicators (RSI 33.5, MACD negative, price below DMA 50 & 200) show bearish momentum. Overall, the company is financially sound but currently expensive and facing growth challenges, making it a cautious candidate for long-term investment.
💰 Ideal Entry Zone: ₹1,200 – ₹1,300, closer to support levels, aligning with valuation comfort and technical positioning.
📈 Exit / Holding Strategy: Existing holders should maintain a medium-term horizon (2–3 years) but monitor earnings closely. Consider partial profit booking if the price revisits ₹1,600–₹1,700. Long-term holding is not recommended unless ROE/ROCE improve and growth stabilizes.
Positive
- Debt-free balance sheet (Debt-to-equity 0.00).
- ROCE (18.7%) and ROE (14%) reflect reasonable capital efficiency.
- EPS at ₹35.3 supports earnings visibility.
- Stable PAT trend (₹42.3 Cr vs ₹42.9 Cr) shows resilience.
Limitation
- High P/E (36.4) compared to industry average (25.2) suggests overvaluation.
- PEG ratio of -6.04 indicates weak growth prospects.
- Dividend yield (0.78%) is modest compared to peers.
- Technical indicators (MACD negative, RSI near 33) show weak short-term momentum.
Company Negative News
- Quarterly profit variance (-3.43%) highlights earnings weakness.
- Sharp correction from ₹2,449 to ₹1,285 shows investor caution.
Company Positive News
- FII (+0.01%) and DII (+0.13%) holdings increased slightly, signaling institutional confidence.
- 52-week performance (+5.92%) highlights resilience despite volatility.
Industry
- Industry P/E at 25.2 is lower than company’s P/E (36.4), suggesting peers may offer better value.
- Chemicals sector growth supported by rising demand in pharma and industrial applications.
Conclusion
⚖️ ALKYLAMINE is financially stable with debt-free status and decent ROE/ROCE, but current valuations are expensive and growth prospects weak. Ideal entry is around ₹1,200–₹1,300. Existing holders should maintain a 2–3 year horizon, booking profits near ₹1,600–₹1,700. While fundamentals are stable, high P/E and weak growth metrics warrant cautious investment.